
Common Drugs Can Leave Long-Term Effects On Your Gut Microbiome
New research reveals that medications taken years-even decades-ago can leave lasting marks on the gut microbiome, reshaping the balance of microbes long after treatment stops. Scientists analyzing over 2,500 participants from the Estonian Biobank found that the effects are not limited to antibiotics.
Antidepressants, beta-blockers, proton pump inhibitors, and anxiety medications also disrupt gut ecosystems, sometimes in unexpected ways. Even drugs from the same class can have different impacts on microbial communities.
Study Highlights
Researchers at the University of Tartu Institute of Genomics examined stool samples and prescription records, discovering that most drugs analyzed were linked to measurable changes in the gut microbiome. Many of these changes persisted long after patients discontinued treatment. The study is published in mSystems, the journal of the American Society for Microbiology.
Benzodiazepines, commonly prescribed for anxiety, produced microbial alterations similar to broad-spectrum antibiotics. Other drugs, such as selective serotonin reuptake inhibitors (SSRIs) and proton pump inhibitors, also showed lasting effects. Follow-up testing confirmed predictable shifts in gut microbes when specific medications were started or stopped, suggesting a likely cause-and-effect relationship.
Why This Matters
“Most microbiome studies only consider current medications, but our results show that past drug use is a surprisingly strong factor in explaining individual microbiome differences,” said Dr. Oliver Aasmets, lead author.
Professor Elin Org, the study's corresponding author, emphasized that these findings encourage researchers and clinicians to consider a patient's medication history when studying the microbiome and its links to disease.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Crypto Market Update: Pepeto Advances Presale With Staking Rewards And Live Exchange Demo
- Kucoin Appeals FINTRAC Decision, Reaffirms Commitment To Compliance
- Cregis And Sumsub Host Web3 Compliance And Trust Summit In Singapore
- Chartis Research And Metrika Release Comprehensive Framework For Managing Digital Asset Risk
- Nodepay Launches Crypto's Largest Prediction Intelligence Platform
- Schoenherr Opens London Liaison Office As Gateway To Central Eastern Europe
Comments
No comment